Cellective Therapeutics' Seed VC Round

Cellective Therapeutics raised a round of funding on August 11, 2003. Investors include InterSouth Partners.

Cellective was developing several new pharmaceuticals treating B Cell related cancer and immune diseases. The technology is based on research by Founder Tom Tedder, Chairman of Immunology at Duke Univ…

Articles about Cellective Therapeutics' Seed VC Round: